Chicago Partners Investment Group LLC Buys 4,904 Shares of Agilent Technologies, Inc. $A

Chicago Partners Investment Group LLC increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 104.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,593 shares of the medical research company’s stock after purchasing an additional 4,904 shares during the period. Chicago Partners Investment Group LLC’s holdings in Agilent Technologies were worth $1,156,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Paradiem LLC acquired a new position in Agilent Technologies in the first quarter valued at about $3,364,000. LGT Fund Management Co Ltd. grew its position in shares of Agilent Technologies by 14.6% during the 1st quarter. LGT Fund Management Co Ltd. now owns 2,820 shares of the medical research company’s stock worth $321,000 after buying an additional 360 shares during the period. Associated Banc Corp grew its position in shares of Agilent Technologies by 30.8% during the 1st quarter. Associated Banc Corp now owns 3,236 shares of the medical research company’s stock worth $369,000 after buying an additional 762 shares during the period. Diversify Wealth Management LLC increased its stake in shares of Agilent Technologies by 125.8% in the 1st quarter. Diversify Wealth Management LLC now owns 3,366 shares of the medical research company’s stock valued at $375,000 after acquiring an additional 1,875 shares during the last quarter. Finally, Citizens Financial Group Inc. RI increased its stake in shares of Agilent Technologies by 89.4% in the 1st quarter. Citizens Financial Group Inc. RI now owns 4,288 shares of the medical research company’s stock valued at $489,000 after acquiring an additional 2,024 shares during the last quarter. Institutional investors own 87.41% of the company’s stock.

Agilent Technologies Trading Down 0.2%

A opened at $134.92 on Thursday. The firm’s fifty day simple moving average is $126.82 and its 200 day simple moving average is $125.60. The stock has a market capitalization of $38.11 billion, a P/E ratio of 27.09, a P/E/G ratio of 2.40 and a beta of 1.25. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on A shares. HSBC decreased their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target on the stock. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price target for the company from $150.00 to $145.00 in a report on Thursday, May 28th. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Finally, Barclays raised their price objective on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 24th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $159.35.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.